Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Oct 2005):

Gender differences in response to lorazepam in a human drug discrimination study.

Full Abstract

Gender differences in the discriminative stimulus properties of drugs of abuse have sometimes been reported, although we have previously found no differences in subjective or discriminative responses in human subjects acquiring an alcohol discrimination. The aim of the present work was to determine if there were gender differences in the effects of lorazepam, a benzodiazepine-receptor agonist which substituted for the alcohol stimulus in trained social drinkers. Volunteers who had already acquired an alcohol (0.2g/kg) placebo discrimination were administered (double-blind) either placebo (nine females, nine males) or lorazepam 2mg (six females, six males). They then sampled a series of five drinks and rated each one for likeness to the training stimulus (the generalization response). In addition they completed rating scales for subjective effects and the Digit Symbol Substitution Test (DSST). Lorazepam substituted for the alcohol stimulus equally in both sexes and increased associated scores for lightheadedness. Females however, showed a much greater DSST performance impairment following lorazepam, compared with males. This effect was independent of body weight differences and sedation. These results are discussed in the light of current knowledge of gender differences in response to drugs of abuse and suggest that the stimulus and cognitive effects of benzodiazepine-receptor agonists are modulated by different brain mechanisms.

 

Author information

Author/s: Jackson, Anne (A); Stephens, David (D); Duka, Theodora (T);

Affiliation: Department of Pharmacology, University of Brighton, School of Pharmacy and Biomolecular Sciences, Moulsecoomb, Brighton BN2 2GJ, UK. anne.jackson(-atsign-)brighton.ac.uk

Grants: (Agency:Wellcome Trust)

Journal and publication information

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal: Journal of psychopharmacology (Oxford, England) (J Psychopharmacol), published in United States. (Language: eng)

Reference: 2005-Nov; vol 19 (issue 6) : pp 614-9

Dates: Created 2005/11/07; Completed 2006/02/09; Revised 2007/08/13;

PMID: 16272183, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Anti-Anxiety Agents (0) ; Lorazepam (846-49-1)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

4/29/1986
1/24/2007
Higher Relevance Score (36)
Lower Relevance Score (29)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index